Haleos Labs Limited

  • BSE Code : 540679
  • NSE Symbol : HALEOSLABS
  • ISIN : INE320X01016
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,260.00 10.90(0.87%)

Open Price ()

1,246.00

Prev. Close ()

1,249.10

Volume (No’s)

592

Market Cap ()

377.64

Low Price ()

1,244.80

High Price ()

1,260.00

 

Board Meetings

Start Date End Date Purpose
04-Nov-2025 10-Nov-2025 SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30 2025 and any other item as may be decided by the Board of Directors. Enclosed -- Outcome of 95th Board meeting. (As Per Bse Announcement dated on 10/11/2025)
06-Aug-2025 11-Aug-2025 SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025 Board report for the year 2024-25 and fixing the date of 19th Annual General Meeting any other item as may be decided by the Board of Directors. Enclosed -- Outcome of 94th Board Meeting. Enclosed unaudited financial results for the quarter ended June 30, 2025.. (As Per BSE Announcement Dated on:11.08.2025)
22-May-2025 29-May-2025 SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve audited financial results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2025discuss to recommend dividend for the financial year 2024-25 if any and any other item as may be decided by the Board of Directors. Enclosed -- outcome of Board Meeting. (As per BSE Announcement Dated on 27/05/2025) Reappointment of Secretarial Auditors for 5 years and Cost Auditors for the year 2025-26. Enclosed financial results for the quarter and year ended 31st March, 2025. (As per BSE Announcement Dated on 29/05/2025)
07-Feb-2025 12-Feb-2025 SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2024 and any other item as may be decided by the Board of Directors. Enclosed - outcome of Board Meeting. (As Per BSE Announcement dated on 12.02.2025)
08-Nov-2024 13-Nov-2024 SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30. 2024 and any other item as may be decided by the Board of Directors. Outcome of Board meeting (As Per BSE Announcement Dated on: 13/11/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew